Mesenchymal stem cells: clinical applications and biological characterization

被引:1260
作者
Barry, FP [1 ]
Murphy, JM [1 ]
机构
[1] Osiris Therapeut Inc, Baltimore, MD 21231 USA
关键词
mesenchymal stem-cell; tissue engineering; allogeneic cell therapy; bone marrow; cell engraftment;
D O I
10.1016/j.biocel.2003.11.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mesenchymal stem cells (MSCs) have been isolated from bone marrow, periosteum, trabecular bone, adipose tissue, synovium, skeletal muscle and deciduous teeth. These cells have the capacity to differentiate into cells of connective tissue lineages, including bone, fat, cartilage and muscle. A great deal has been learned in recent years about the isolation and characterization of MSCs, and control of their differentiation. These cells have generated a great deal of interest because of their potential use in regenerative medicine and tissue engineering and there are some dramatic examples, derived from both pre-clinical and clinical studies, that illustrate their therapeutic value. This review summarizes recent findings regarding the potential clinical use of MSCs in cardiovascular, neural and orthopaedic applications. As new methods are developed, there are several aspects to the implanted cell-host interaction that need to be addressed before we can fully understand the underlying mechanisms. These include the host immune response to implanted cells, the homing mechanisms that guide delivered cells to a site of injury and the differentiation in vivo of implanted cells under the influence of local signals. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:568 / 584
页数:17
相关论文
共 103 条
  • [1] Therapeutic angiogenesis using autologous bone marrow stromal cells: Improved blood flow in a chronic limb ischemia model
    Al-Khaldi, A
    Al-Sabti, H
    Galipeau, J
    Lachapelle, K
    [J]. ANNALS OF THORACIC SURGERY, 2003, 75 (01) : 204 - 209
  • [2] Archer CW, 1996, J ANAT, V189, P23
  • [3] Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect
    Arinzeh, TL
    Peter, SJ
    Archambault, MP
    van den Bos, C
    Gordon, S
    Kraus, K
    Smith, A
    Kadiyala, S
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2003, 85A (10) : 1927 - 1935
  • [4] The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells
    Barry, F
    Boynton, R
    Murphy, M
    Zaia, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 289 (02) : 519 - 524
  • [5] Chondrogenic differentiation of mesenchymal stem cells from bone marrow: Differentiation-dependent gene expression of matrix components
    Barry, F
    Boynton, RE
    Liu, BS
    Murphy, JM
    [J]. EXPERIMENTAL CELL RESEARCH, 2001, 268 (02) : 189 - 200
  • [6] The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105)
    Barry, FP
    Boynton, RE
    Haynesworth, S
    Murphy, JM
    Zaia, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (01) : 134 - 139
  • [8] Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2
    Bianchi, G
    Banfi, A
    Mastrogiacomo, M
    Notaro, R
    Luzzatto, L
    Cancedda, R
    Quarto, R
    [J]. EXPERIMENTAL CELL RESEARCH, 2003, 287 (01) : 98 - 105
  • [9] Axis of evil: molecular mechanisms of cancer metastasis
    Bogenrieder, T
    Herlyn, M
    [J]. ONCOGENE, 2003, 22 (42) : 6524 - 6536
  • [10] Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells
    Bruder, SP
    Kurth, AA
    Shea, M
    Hayes, WC
    Jaiswal, N
    Kadiyala, S
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 1998, 16 (02) : 155 - 162